Chugai Pharmabody Research
Seng Koon LIM is an IP Manager/Director at Chugai Pharmabody Research, leading the identification and development of IP opportunities for technology and drug R&D projects in Singapore and Japan. With a background in biotech and pharma, previously serving as a Patent Examiner at IPOS and an Innovation Manager at IPI Singapore, Seng Koon has a strong track record in patent drafting, portfolio management, and conducting due diligence for licensing opportunities. Seng Koon LIM holds a PhD in Interdisciplinary materials science & bioengineering and is a graduate of the National University of Singapore's Graduate Certificate in Intellectual Property Law program.
This person is not in the org chart
This person is not in any offices
Chugai Pharmabody Research
1 followers
In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.